It also depends on the type and quality of a news publisher. Deciphera Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can ...
In the News 5/29/24 – RespireRx Pharmaceuticals Inc. Announces a Department of Defense Award to Fund a Phase 2 Clinical Study to Determine the Safety and Efficacy of CX1739, its Lead AMPAkine, to Improve Bladder Function in Patients with Spinal Cord Injury ...
In the News SunGen Pharma Rebrands as Praxgen Pharmaceuticals Oakrum Pharma and SunGen Pharma Announce U.S. Launch of Generic Medrol® (Methylprednisolone) Oakrum Pharma and SunGen Pharma Announce U.S. Launch of Generic Medrol® (Methylprednisolone) ...
MedCity News Daily Newsletter Sign up and get the latest news in your inbox. Enter your email address Subscribe Now We will never sell or share your information without your consent. See our privacy policy. MedCity Influencers The Converging Therapeutic Landscape of Oncology and Immunology:...
In the News SunGen Pharma Rebrands as Praxgen Pharmaceuticals Oakrum Pharma and SunGen Pharma Announce U.S. Launch of Generic Medrol® (Methylprednisolone) Oakrum Pharma and SunGen Pharma Announce U.S. Launch of Generic Medrol® (Methylprednisolone) ...
VISEN Pharmaceuticals, Emerging Expert in Endocrinology Achieving better treatment processes and outcomes by combining global expertise and strength in endocrine therapies
Explore the difference between biologics and biosimilars and learn more about Teva’s innovative work in this space Discover more What are Biologics and Biosimilars? Medical Device Engineering: The Teva Story From injection pens to inhalers, medical devices have revolutionized treatment delivery. At Tev...
Mr. Pony LU, CEO of VISEN Pharmaceuticals, said, "As the first upcoming commercial product of VISEN Pharmaceuticals, lonapegsomatropin has demonstrated statistically significantly greater efficacy than the daily hGH in the Chinese Phase 3 clinical results. The BLA acceptance represents a significant ste...
Committed to addressing unmet needs in rare diseases News Releases Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Acadia Pharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on February 26, 2025 ...
CNS Pharmaceuticals is a biotechnology company specializing in the development of novel treatments for brain tumors.